Biotechnology Industry MOUs

Memorandum of Understanding, dated November 20, 2022, by and between the Registrant and Jack Zamora (VITRO DIAGNOSTICS INC, Filed With SEC on January 29, 2024)

Memorandum of Understanding, dated October 10, 2023, by and between ABT Holding Company and HEALIOS K.K (ATHERSYS, INC, Filed With SEC on November 16, 2023)

Letter of understanding between QRONS, Inc and Quick Capital, LLC, dated December 7, 2022 (Qrons Inc., Filed With SEC on March 31, 2023)

Memorandum of Understanding, dated November 20, 2022, by and between the Registrant and Jack Zamora (VITRO DIAGNOSTICS INC, Filed With SEC on January 30, 2023)

Memorandum of Understanding, dated October 12, 2022, between Statera Biopharma, Inc. and Holobeam Technologies, Inc (CLEVELAND BIOLABS INC, Filed With SEC on October 17, 2022)

Letter of Understanding between Myovant Sciences, Inc. and Matthew Lang (Myovant Sciences Ltd., Filed With SEC on July 27, 2022)

Confirmation of Mutual Understanding, dated March 24, 2022 (SPHERIX INC, Filed With SEC on March 28, 2022)

Memorandum of Understanding between the Shareholders of HalioDx and the Registrant (VERACYTE, INC., Filed With SEC on July 29, 2021)

Memorandum of Understanding, dated March 14, 2019, by and among the Registrant, the University of Vienna, and the Regents of the University of California (Caribou Biosciences, Inc., Filed With SEC on July 1, 2021)

Windlas Mateon MOU (MATEON THERAPEUTICS INC, Filed With SEC on September 28, 2020)

Memorandum of Understanding (VITRO DIAGNOSTICS INC, Filed With SEC on June 4, 2020)

Letter of Understanding, dated November 8, 2017, between The Regents of the University of Colorado and Ocugen, Inc (HISTOGENICS CORP, Filed With SEC on June 14, 2019)

Memorandum of Understanding, dated December 26, 2017, by and among the Company and the parties named therein (AVEO PHARMACEUTICALS INC, Filed With SEC on December 26, 2017)

Memorandum of Understanding by and between Biostage, Inc. and Bin Zhao, dated December 11, 2017 (Biostage, Inc., Filed With SEC on December 14, 2017)

MEMORANDUM OF UNDERSTANDING (Biostage, Inc., Filed With SEC on June 27, 2017)

AMENDMENT TO MEMORANDUM OF UNDERSTANDING (VITRO DIAGNOSTICS INC, Filed With SEC on April 19, 2017)

MEMORANDUM OF UNDERSTANDING (VITRO DIAGNOSTICS INC, Filed With SEC on March 29, 2017)

BINDING MEMORANDUM OF UNDERSTANDING (PharmaCyte Biotech, Inc., Filed With SEC on July 29, 2016)

MEMORANDUM OF UNDERSTANDING Principles of Research and LicenseAgreement June 1, 2015 (IMMUNE PHARMACEUTICALS INC, Filed With SEC on June 11, 2015)

MEMORANDUM OF UNDERSTANDING Principles of Research and LicenseAgreement March 10, 2015 (IMMUNE PHARMACEUTICALS INC, Filed With SEC on May 15, 2015)

March 25, 2015 Memorandum of Understanding with CureCell Co., Ltd (Orgenesis Inc., Filed With SEC on April 9, 2015)

March 23, 2015 Memorandum of Understanding with Global Stem Cell & Regenerative Medicine Acceleration Center (Orgenesis Inc., Filed With SEC on April 9, 2015)

Letter of Understanding (CytoDyn Inc., Filed With SEC on February 11, 2015)

Memorandum of Understanding, dated July 31, 2013, between Nemus and University of Mississippi, National Center for Natural Products Research (Emerald Bioscience, Inc., Filed With SEC on November 3, 2014)

MEMORANDUM OF UNDERSTANDING (PharmaCyte Biotech, Inc., Filed With SEC on August 4, 2014)

ConfidentialMaterials omitted and filed separately with the Securities and Exchange Commission.Asterisks denote omissions. MEMORANDUMOF UNDERSTANDING (the MOU) July25, 2006 (Momenta Pharmaceuticals, Inc., Filed With SEC on November 8, 2006)

Memorandum of Understanding (Esperion Therapeutics, Inc., Filed With SEC on March 14, 2002)

Category

Industry

Companies

Contracts

MOUs in the Biotechnology Industry